6Yzquierdo SL, Lemus D, Echem enclin M, et al. Evaluation of phage assay for rapid phenotypic detection of rifampicin resis tanee in mycobaterium tuber culasis[J]. Anclin Mierrobiol Antimierob, 2006, 5:11.
4Cornaglia G, Lonnroth A, Struelens M. Report from the European Conference on the Role of Research in Combating Antibiotic Resistance, 2003. Clin Microbiol Infect, 2004, 10:473-497.
5Marchese A,Schito GC. Role of global surveillance in combating bacterial resistance. Drugs, 2001,61:167-173.
6Jones RN, Craig WA, Ambrose PG, et al. Reevaluation of Enterobacteriaceae MIC/disk diffusion zone diameter regression scattergrams for 9 beta- lactams: adjustments of breakpoints for strains producing extended spectrum beta-lactamases. Diagn Microbiol Infect Dis, 2005, 52:235-246.
7Pottumarthy S, Deshpande LM, Sader HS, et al. Reevaluation of the cefepime minimal inhibitory concentrations and disk diffusion test zone diameter relationship for a worldwide collection of Enterobacteriaceae enriched for extended-spectrum beta-lactamase-producing organisms. Diagn Microbiol Infect Dis, 2005, 52:95-99.
8Clinical and Laboratory Standards Institute (Fomerly NCCLS ) M100-S18. Performance standards for antimierobial susceptibility testing; Eighteenth Informational Supplement. Wayne, PA 2008.
9Rogues AM, Dumartin C, Amadeo B, et al. Relationship between rates of antimicrobial consumption and the incidence of antimicrobial resistance in Staphylococcus aureus and Pseudomonas aeruginosa isolates from 47 French hospitals. Infect Control Hosp Epidemiol, 2007, 28 : 1389-1395.
10Meyer E, Schwab F, Gastmeier P,et al. MethieiUin-resistant Staphylococcus aureus in German intensive care units during 2000-2003: data from Project SARI (Surveillance of antimicrobial use and antimicrobial resistance in intensive care units). Infect Control Hosp Epidemiol, 2006, 27: 146-154.
